NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered NAD+ from Shanghai ERP peptide Biotechnology? Mail in a sample (US only) and let us test it.

Test my supply
+16 more ↓
33%
Finnrick rating
#4 of 19 NAD+ vendors
2 of 3 classifiable tests passed
natural 67% · customers 4.3★ (1)
methodology · Purity focus
Finnrick analysis · NAD+

Shanghai ERP peptide Biotechnology's purity-focus record is strongest in Tirzepatide and Retatrutide, where deeper, recent identity/purity results are steadier after earlier misses. The catalog remains dispersed because HGH and TB-500 show recent purity/fill failures, with uneven batch IDs limiting lot-level confidence.

methodology →
vendor intelligence report
Vendor Intelligence Report: Shanghai ERP peptide Biotechnology

ERP’s public footprint splits across WordPress, BeikeShop, and a Louise wholesale subdomain, with placeholder policies and mismatched contacts. The report traces Genesis-branded vials, crypto payment rails, a New Hampshire fulfillment clue, and a documented endotoxin dispute.

31 pages8 risk factors assessed3 Jul 2026
read the report
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%12 Mar 2026: 78%29 Mar 2026: 78%23 Jul 2026: 37%29 Sept 2026: current 33%78%37%33%Mar 26Sep 26
Showing NAD+ tests only
Shanghai ERP peptide Biotechnology NAD+ test history
COA-backed lab tests

About Shanghai ERP peptide Biotechnology test results from Finnrick

Shanghai ERP peptide Biotechnology is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 14 peptides and 149 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Shanghai ERP peptide Biotechnology peptides in this dataset are BPC-157 (10 tests), Cagrilintide (3 tests) and GHK-Cu (12 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 149 recent tests.

Corrections
No corrections.
Peptide testing

Ordered NAD+ from Shanghai ERP peptide Biotechnology? Mail in a sample (US only) and let us test it.

Test my supply